![]()  | |
| Names | |
|---|---|
| Preferred IUPAC name
 1-(6-Bromo-2H-1,3-benzodioxol-5-yl)propan-2-amine  | |
| Other names
 2-Bromo-4,5-methylenedioxyamphetamine 2-(2-Bromo-4,5-methylenedioxyphenyl)ethan-1-methyl-amine  | |
| Identifiers | |
3D model (JSmol)  | 
|
| ChemSpider | |
PubChem CID  | 
|
| UNII | |
CompTox Dashboard (EPA)  | 
|
  | |
  | |
| Properties | |
| C11H17BrNO2 | |
| Molar mass | 275.166 g·mol−1 | 
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). 
Infobox references  | |
2-Bromo-4,5-methylenedioxyamphetamine (6-Bromo-MDA) is a lesser-known psychedelic drug and a substituted amphetamine. It was first synthesized by Alexander Shulgin. In his book PiHKAL, the dose is listed as 350 mg and the duration unknown.[1] It produces stimulant effects but with no psychedelic or empathogenic action.[1] Very little data exists about its pharmacological properties, metabolism, and toxicity.
See also
References
    This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.
